There is disclosed a genus of optionally substituted Schiff base condensation products (and the carba analogs thereof) comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity. The compounds are useful for treating a variety of diseases involving inflammatory activity or pro-inflammatory cytokine responses, such as autoimmune diseases, asthma, arthritis, EAE, ARDS and various forms of sepsis and septic shock, and other conditions characterized by underlying MIF responses including, for instance, tumor growth and neovascularization.

Показано genus опционно замененных продуктов конденсации schiff низкопробных (и аналогов carba thereof) состоя из компонента amino acid и компонент бензальдегида, то имеет деятельность при антагониста MIF (фактора переселения макрофага inhibitory). Смеси полезны для обрабатывать разнообразие заболеваний включая воспалительную деятельность или про-vospalitel6nye реакции cytokine, such as аутоиммунные заболевания, астма, артрит, EAE, ARDS и различные формы sepsis и септического удара, и другия условия, котор характеризует основными реакциями MIF включая, for instance, ростом тумора и neovascularization.

 
Web www.patentalert.com

< Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments

< Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)

> Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic , and medicament containing them

> Treating NIDDM with RXR agonists

~ 00079